hcq

Codebase Receives Positive Technical Study Results for HCQ Transdermal Patch Technology

Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027*, Company to investigate Spin Out of Asset

Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on the continued development of the Company's proposed transdermal delivery technology for hydroxychloroquine (HCQ), as first announced in April 2020

The Company engaged TRPL (Transdermal Research Pharm Laboratories) of Long Island City of New York, to conduct a feasibility study which indicates that HCQ has all the required parameters to be a transdermal candidate.

In recognition of the potential value of this legacy asset, and in light of the Company's current focus upon the blockchain and related emerging technology ecosystem, Code is investigating spinning out its interest in the transdermal delivery technology for HCQ. Details on any such spin out will be provided in the coming weeks as the Company explores deal structures with its partners to ensure Code shareholders benefit.

Code has a 49% interest in Glanis Pharmaceuticals Inc., an arms-length private company which holds provisional US patents for transdermal and oral mucosal delivery of hydroxychloroquine and chloroquine (CQ). The drug is FDA approved as a treatment against malaria, lupus, and rheumatoid arthritis. On the basis of positive results from the feasibility study, the parties are beginning the process from provisional to full patent.

Highlights

  • Market for HCQ forecast to reach $6 billion by 2027* as FDA approved treatment for malaria, lupus, and rheumatoid arthritis
  • Code receives positive technical feasibility study results indicating HCQ has all the required parameters to be delivered transdermally
  • HCQ transdermal treatment for malaria, lupus and rheumatoid arthritis patients likely to resolve oral tablet side effects as it would bypass the first pass metabolism

Code has received interest in the application of HCQ in a transdermal patch for the underserved patients with malaria, lupus, and rheumatoid arthritis. Current oral tablet delivery of HCQ comes with side effects that transdermal delivery is likely to resolve.

Transdermal delivery can provide a drug plasma concentration at predetermined rate for a predetermined period of time. Safe, consistent doses will make the drug much more effective at reduced dosages required because the GI system is avoided with transdermal delivery. This new delivery method should eliminate or reduce a number of the common side effects of the oral tablet treatment, including nausea, vomiting, loss of appetite, diarrhea, dizziness, or headache, by providing controlled constant delivery.

TRPL has a combined 75 years of expertise in transdermal delivery systems and provides the capacity, equipment and capabilities to advance the development program for a hydroxychloroquine molecule for oral mucosal delivery from research, testing, regulatory approvals through to launch of the hydroxychloroquine oral mucosal delivery system.

The Company also announced that it has engaged Ahead of the Herd for $70,000 as a consultant to provide marketing services over a 6-month period.

*https://www.prnewswire.com/news-releases/hydroxychloroquine-market-size-worth-around-us-6-bn-by-2027-301058526.html

About Codebase Ventures Inc.

Codebase Ventures Inc. seeks early-stage investments in sectors that have significant upside. We seek innovators who are establishing tomorrow's standards. We support those innovators and help take their ideas to market.

For further information, please contact:

George Tsafalas - Ivy Lu
Investor Relations
Telephone: Toll-Free (877) 806-CODE (2633) or 1 (778) 806-5150
E-mail: IR@codebase.ventures

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

SOURCE: Codebase Ventures Inc.



View source version on accesswire.com:
https://www.accesswire.com/638539/Codebase-Receives-Positive-Technical-Study-Results-for-HCQ-Transdermal-Patch-Technology

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Bitcoin on fire with a price chart going up.

Is Now a Good Time to Buy Bitcoin? (Updated 2024)

Bitcoin is prone to price volatility, with wide swings to the upside and downside. The most recent downturn comes alongside market turmoil triggered by weak jobs data and fears of a looming recession.

Bitcoin's value has rallied over the last few quarters, increasing from about US$26,000 in mid-September 2023 to an all-time high of around US$73,000 in mid-March of 2024.

There have been several notable events in the Bitcoin space in that time, including the much-anticipated launch of the first US spot Bitcoin exchange-traded funds (ETFs) in January and the fourth Bitcoin halving event that occurred on April 19. Bitcoin's value dropped to US$39,500 in January after the ETF launch but soared through February and early March to its new high.

Keep reading...Show less
Bitcoin with US flags.

How Will the US Election Affect the Crypto Industry?

As the world continues to embrace digital currencies and blockchain technology, the cryptocurrency industry is solidifying its position on a broad scale as a key part of the global economy.

Six months in, 2024 has already been a big year for crypto, with milestones including a new all-time high for the Bitcoin price, and the approval of spot Bitcoin and Ether exchange-traded funds in the US.

Heading into the second half of the year, the US election is expected to have far-reaching implications for the crypto market in America and potentially beyond. Issues such as regulation, taxation and the integration of cryptocurrencies into the mainstream economy will be critical in shaping the future of this dynamic sector.

Keep reading...Show less
Bitcoin price chart going up.

Bitcoin: A Price History of the First Cryptocurrency (Updated 2024)

Bitcoin, the most well-known cryptocurrency, paved the way for the cryptocurrency asset class.

Now the cryptocurrency of choice, its meteoric rise was unlike any other commodity, resource or asset. Bitcoin’s price rose more than 1,200 percent from March 2020 to reach US$69,044 on November 10, 2021.

The currency showcased its famous volatility in the following year, falling as low as US$15,787 by November 2022 amid economic uncertainty and a wave of negative media coverage.

The cryptocurrency started 2024 just below US$45,000 and has seen substantial gains in the first half of this year. Bitcoin reached its new all-time high price of US$73,115 on March 11, 2024.

Keep reading...Show less
Canadian flag with geometric patterns overlaid.

Top Canadian Crypto Mining Stocks

Canadian crypto stocks offer investors exposure to the booming cryptocurrency markets.

Cryptocurrencies are digital currencies that are independent of traditional banking systems. They exist on a blockchain, a secure and immutable transaction record shared among many computer nodes in a network.

The most well-known cryptocurrency is Bitcoin, and the process of generating new Bitcoin units is called mining. When Bitcoin was new, it was easy enough for tech-savvy individuals to mine their own tokens using store-bought hardware. However, as Bitcoin has grown in popularity, mining has become a difficult and expensive process.

That’s why these days most mining is done at the industrial level. Large corporations with capital and the right equipment at their disposal can mine tens or even hundreds of Bitcoin every day. Buying shares of companies that mine crypto or provide crypto services is a way for investors to reap the potential benefits this industry has to offer without risking major losses.

Keep reading...Show less
Canada flag and various crypto coins, including Bitcoin and Ether.

13 Canadian Crypto ETFs (Updated 2024)

Cryptocurrencies such as Bitcoin and Ethereum offer an alternative route for building and storing wealth. While directly holding these digital assets is a popular option, investors are also clamoring for financial products such as crypto exchange-traded funds (ETFs).

Canada first launched Bitcoin and Ethereum ETFs in 2021. These Canadian Bitcoin and Ethereum ETFs allow investors to place returns in tax-sheltered accounts like tax-free savings accounts or registered retirement savings plans.

“There is a high demand for a Bitcoin product that has all the features that people love about ETFs — that they trade on an exchange, that they’re liquid,” Ross Mayfield, investment strategy analyst at Robert W. Baird & Co., told Bloomberg in mid-2021.

Keep reading...Show less
Vice President Kamala Harris with a US flag and crypto coins.

Tech 5: Aide Says Harris Supports Policies to Expand Crypto Sector, AMD to Buy ZT Systems

Investors proceeded cautiously through the week's opening days, but the tone shifted on Friday (August 23) afternoon in response to an optimistic announcement from US Federal Reserve Chair Jerome Powell

In a Jackson Hole speech, he signaled that the Fed is ready to begin cutting interest rates.

Crypto markets also saw a surge, breaking free from a weeks-long pricing gridlock. In company news, Waymo introduced a new version of its self-driving technology, marking another milestone in a series of wins in recent months.

Keep reading...Show less

Latest Press Releases

Related News

×